| 1 |
32580291 | An Anti-PSMA Immunotoxin Reduces Mcl-1 and Bcl2A1 and Specifically Induces in Combination with the BAD-Like BH3 Mimetic ABT-737 Apoptosis in Prostate Cancer Cells. | 2020 Jun 22 |
1 |
| 2 |
29855540 | DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-β signaling pathway. | 2019 Mar |
1 |
| 3 |
27086916 | Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. | 2017 Jul 18 |
1 |
| 4 |
24268771 | Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors. | 2013 Nov 27 |
1 |
| 5 |
21768359 | Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. | 2012 Feb 21 |
1 |
| 6 |
22374700 | Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival. | 2012 Jun 14 |
1 |
| 7 |
23213401 | ABT-737 synergizes with Bortezomib to kill melanoma cells. | 2012 Feb 15 |
1 |
| 8 |
19726085 | Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. | 2010 Apr |
1 |
| 9 |
20516119 | Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis. | 2010 Jul 1 |
1 |
| 10 |
20534453 | BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. | 2010 Jun 15 |
1 |
| 11 |
18807035 | Immunosensitization with a Bcl-2 small molecule inhibitor. | 2009 May |
1 |
| 12 |
19839062 | BH3-only protein bid participates in the Bcl-2 network in healthy liver cells. | 2009 Dec |
1 |
| 13 |
18591385 | The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies. | 2008 Oct 1 |
1 |